E L C Pharmaceuticals Private Limited
About E L C Pharmaceuticals Private Limited
Data last updated:
E L C Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 December 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1998PTC097310. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shyam Sunder Gadle (Managing Director) and Nisha Gadle.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 2 Wz – 53A Prithvi Park Tilak Nagar, New Delhi, Delhi, India – 110018.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
E L C Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 2 Wz – 53A Prithvi Park Tilak Nagar, New Delhi, Delhi, India – 110018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of E L C Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of E L C Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of E L C Pharmaceuticals Private Limited, buy the company report.
Financials of E L C Pharmaceuticals Private Limited
FY 2025 filings availableE L C Pharmaceuticals Private Limited reported revenue of ₹8,000 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of E L C Pharmaceuticals Private Limited, buy the company report.
Board of directors of E L C Pharmaceuticals Private Limited
E L C Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisha Gadle | Director | 17 Dec 1998 | 27 Years 10 Months | Current |
| Shyam Sunder Gadle | Managing Director | 03 Dec 1998 | 27 Years 10 Months | Current |
Auditor
E L C Pharmaceuticals Private Limited is audited by ARUN SINGH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUN SINGH & CO | FY 2020 | 011863N |
Shareholding
The shareholding of E L C Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of E L C Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving E L C Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for E L C Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
E L C Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of E L C Pharmaceuticals Private Limited, buy the company report.
Recent activity
E L C Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Nisha Gadle was appointed as Director on 17 Dec 1998.
Frequently asked questions
E L C Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 December 1998 (28+ years old) and is registered under CIN U24239DL1998PTC097310.
E L C Pharmaceuticals has 2 current directors:
- Shyam Sunder Gadle - Managing Director
- Nisha Gadle - Director
The latest financial statements of E L C Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. E L C Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of E L C Pharmaceuticals is U24239DL1998PTC097310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
E L C Pharmaceuticals was incorporated on 03 December 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Nisha Gadle was appointed as Director on 17 Dec 1998. Shyam Sunder Gadle was appointed as Managing Director on 03 Dec 1998.
The registered office of E L C Pharmaceuticals is at Shop No. 2 Wz – 53A Prithvi Park Tilak Nagar, New Delhi, Delhi, India – 110018.
E L C Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of E L C Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.